Methods for assessing efficacy of chemotherapeutic agents
OwnerPaul L. Kornblith, Sean McDonaldinventors
Life of this patent
Estimating the term…
Abstract
Methods are provided for accurately predicting efficacy of chemotherapeutic agents. Methods of the invention increase the positive predictive value of chemosensitivity assays by assessing both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance. Results obtained using methods of the invention provide insight into the in vivo effectiveness of a therapeutic, and lead to more effective chemotherapeutic treatment.
Claims26
A method for assessing efficacy of a chemotherapeutic agent, the method comprising:
- conducting an assay to determine whether a chemotherapeutic agent affects cellular phenotype of a sample of tumor cells obtained from a patient;
- determining whether said patient comprises a genetic characteristic associated with resistance to said chemotherapeutic agent;
- and
- assessing efficacy of said chemotherapeutic agent based upon results of said conducting and detecting steps.
A method for selecting a chemotherapeutic agent for treating a patient, the method comprising:
- conducting an assay to determine whether a chemotherapeutic agent effects cellular phenotype of a sample of cells from a patient;
- determining whether cells from said patient comprise a genotypic characteristic associated with resistance to said chemotherapeutic;
- and
- selecting said chemotherapeutic agent for treating said patient if said chemotherapeutic agent effects cellular phenotype of said sample of cells in said conducting step and if said cells in said determining step do not comprise a genotypic characteristic associated with resistance to said chemotherapeutic agent.
A method for assessing efficacy of a chemotherapeutic agent on malignant cells in a patient, the method comprising:
- exposing malignant cells from a patient to a chemotherapeutic agent;
- conducting an assay to determine whether said chemotherapeutic agent effects cellular phenotype of said malignant cells from said patient;
- determining whether a sample of cells from said patient comprise a genotypic characteristic associated with resistance to said chemotherapeutic agent;
- and
- assessing efficacy of said chemotherapeutic agent on said malignant cells from said patient based upon results of said conducting and detecting steps.
Dependencies are inferred from the claim text.